• Vitamin D/VDR Control of Endometrial Decidualization

  2026-09-30

  This study shows that active vitamin D promotes human endometrial stromal cell decidualization through VDR-dependent regulation of CYP19, ESR1, and the local estrogen environment. Its combination of time-course analysis, VDR perturbation, primary-cell validation, and ChIP-qPCR provides a mechanistic framework for understanding how vitamin D status may influence endometrial receptivity.

• Acifran Workflows for HCAR Lipid Signaling

  2026-09-30

  Build reproducible HCAR2/HCAR3 experiments with Acifran by linking receptor activation to cAMP and lipid-metabolism phenotypes. This workflow emphasizes matched receptor controls, solvent discipline, and structure-informed interpretation rather than assuming that one agonist produces identical signaling in every cell context.

• Bafilomycin A1: Designing Better Mitophagy Assays

  2026-09-29

  Bafilomycin A1 is a powerful V-ATPase inhibitor, but interpreting mitophagy experiments requires separating increased autophagic cargo from impaired lysosomal clearance. This guide connects its pharmacology with the BipD–KLHL9/KLHL13/CUL3–IMMT pathway in bacterial infection and provides an assay-focused workflow.

• HotStart™ 2X Green qPCR Master Mix Guide

  2026-09-29

  This practical guide explains how HotStart™ 2X Green qPCR Master Mix supports SYBR Green detection for cDNA and DNA quantification while reducing nonspecific amplification risks associated with reaction setup. It is appropriate for real-time PCR gene expression analysis, RNA-seq validation, and nucleic acid quantification, but it should not be treated as a direct RNA assay or used without instrument- and target-specific validation.

• Meropenem Workflows for Infection Research

  2026-09-28

  Meropenem supports controlled antibacterial, cell-culture, and Gram-negative infection-model experiments when concentration, solvent, and resistance context are documented. This guide converts its PBP-directed activity into reproducible workflows while showing where broad activity should not be confused with efficacy against carbapenem-resistant isolates.

• ATRX Loss Sensitizes High-Grade Glioma to RTK Inhibitors

  2026-09-28

  A 2022 drug-screening study found that ATRX-deficient high-grade glioma cells were more sensitive to several receptor tyrosine kinase and PDGFR inhibitors than comparator cells. The reported increase in cellular toxicity with temozolomide combinations supports testing ATRX status as a stratification variable in preclinical studies and in analyses of relevant clinical trials, while leaving clinical benefit unproven.

• WP1066: JAK2/STAT3 Inhibitor Research Guide

  2026-09-27

  WP1066 is a cell-permeable JAK2/STAT3 inhibitor used to investigate phosphorylation-dependent signaling and cancer-cell responses. Product information describes activity in renal carcinoma and leukemia models, but its inhibitory action must not be conflated with studies in which JAK2/STAT3 activation supports macrophage-mediated bone repair.

• Camptothecin Disrupts FUBP1–FUSE DNA Binding

  2026-09-26

  A drug-library screen identified camptothecin and SN-38 as inhibitors of FUBP1 binding to its single-stranded DNA target, FUSE. The study links this biochemical effect to altered FUBP1 target-gene expression in hepatocellular carcinoma cells, suggesting a possible mechanism alongside topoisomerase I inhibition—not proof of clinical benefit through FUBP1.

• Bestatin Reveals New Layers of Jasmonate Signaling

  2026-09-25

  The study positions bestatin as a chemical-genetic probe for jasmonate signaling: it activates jasmonate-responsive genes and developmental responses, with gene induction requiring COI1-dependent signaling but not strict dependence on jasmonate biosynthesis. Screening for bestatin-resistant Arabidopsis mutants then separated defects in bestatin response from distinct changes in jasmonate sensitivity, providing a route to identify additional pathway components.

• ALC-0159: Designing Better mRNA Readouts

  2026-09-25

  ALC-0159 is a PEG-conjugated lipid excipient used in mRNA lipid nanoparticle formulations. Explore how PET reporter imaging can help distinguish delivery from antigen expression—and how to design experiments that interpret those readouts without over-attributing them to one lipid.

• Radicicol Workflows for Hsp90 Research

  2026-09-24

  Use Radicicol to probe Hsp90-linked adipogenesis, ovarian carcinoma apoptosis, and inflammatory responses—with assay controls that help separate target engagement from nonspecific toxicity. This guide turns the product’s biochemical profile into practical pilot workflows and explains how a recent periodontal stem-cell study can inform assay design without implying a shared mechanism.

• Endothelial SGK1 Mediates Salt-Induced Vascular Stiffening

  2026-09-24

  Zhang et al. identify endothelial SGK1 as a mediator of salt- and mineralocorticoid-associated vascular stiffening, combining mouse genetics with pharmacological and cellular experiments. The results connect SGK1 activity with endothelial actin polymerization and support further mechanistic research, while not establishing SGK1 inhibition as a clinical treatment.

• Separating Growth Arrest from Cancer Cell Killing

  2026-09-23

  Hannah R. Schwartz’s dissertation argues that relative viability and fractional viability capture distinct components of anticancer drug response: changes in proliferation and cell killing. Its central practical lesson is to treat these measurements as complementary rather than interchangeable, while tracking how their relationship changes over time.

• Sulfo-NHS-Biotin for EV Protein Labeling

  2026-09-23

  Sulfo-NHS-Biotin enables aqueous, amine-selective labeling of intact cells, extracellular vesicles, and purified proteins without organic-solvent handling. This guide connects practical surface-protein workflows with EV-based targeted protein degradation studies, emphasizing controls that distinguish EV capture, protein abundance, and true target depletion.

• From DNA Synthesis to NSCLC Translation

  2026-09-22

  A mechanistic and translational framework for using EdU flow cytometry to connect CDK1–APE1 biology, cell-cycle pharmacodynamics, and NSCLC therapeutic strategy.

8654 records 1/577 page Next 12345 下5页 Last page